Journal Article DZNE-2025-01377

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Patient-Derived Neurons Exhibit α-Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein-Associated Neurodegeneration.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Wiley New York, NY

Movement disorders 40(12), 2811 - 2818 () [10.1002/mds.70029]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Mitochondrial membrane protein-associated neurodegeneration (MPAN) from the neurodegeneration with brain iron accumulation (NBIA) family is a rare neurodegenerative disease marked by α-synuclein aggregation, brain iron accumulation, and midbrain dopaminergic neuron degeneration.The mechanisms driving neuron vulnerability remain unclear. Our study aimed to develop a patient-derived disease model replicating key pathologies of patient brains.We generated induced pluripotent stem cell-derived midbrain dopaminergic neurons from MPAN patients and examined ultrastructural and biochemical markers of pathology.MPAN patient neurons displayed α-synuclein aggregation, axonal swellings, iron accumulation, and severe membrane destruction. In addition, levels of the major histocompatibility complex class I (MHC-I), linked to cellular stress and neurodegenerative processes, were elevated in patient neurons. Treatment with acetyl-leucine, a potentially neuroprotective compound, decreased MHC-I.This first patient-derived neuronal model of MPAN provides a useful tool for further research aimed at unraveling the complexities of this disease and developing potential therapeutic interventions. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyword(s): MPAN ; NBIA ; dopaminergic neurons ; iPSC disease modeling ; α‐synuclein

Classification:

Contributing Institute(s):
  1. Translational Disease Modeling (AG Burbulla)
  2. Neuroproteomics (AG Lichtenthaler)
  3. Neuronal Cell Biology (AG Misgeld)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)
  2. 351 - Brain Function (POF4-351) (POF4-351)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > M DZNE > M DZNE-AG Lichtenthaler
Document types > Articles > Journal Article
Institute Collections > M DZNE > M DZNE-AG Misgeld
Institute Collections > M DZNE > M DZNE-AG Burbulla
Full Text Collection
Public records
Publications Database

 Record created 2025-12-17, last modified 2025-12-17


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)